Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) is 19.54% higher on its value in year-to-date trading and has touched a low of $4.52 and a high of $11.56 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MRVI stock was last observed hovering at around $7.89 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $7.83, the stock is -7.84% and -10.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.12 million and changing -0.76% at the moment leaves the stock -1.76% off its SMA200. MRVI registered -18.94% loss for a year compared to 6-month gain of -0.51%. The firm has a 50-day simple moving average (SMA 50) of $8.7685 and a 200-day simple moving average (SMA200) of $7.970675.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -13.48% loss in the last 1 month and extending the period to 3 months gives it a 3.43%, and is -5.78% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.70% over the week and 5.49% over the month.
Maravai LifeSciences Holdings Inc (MRVI) has around 650 employees, a market worth around $1.11B and $278.58M in sales. Fwd P/E is 402.78. Profit margin for the company is -47.41%. Distance from 52-week low is 73.23% and -32.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.40%).
with sales reaching $67.55M over the same period.The EPS is expected to shrink by -211.42% this year, but quarterly earnings will post -4.60% year-over-year. Quarterly sales are estimated to grow 1.00% in year-over-year returns.
Maravai LifeSciences Holdings Inc (MRVI) Top Institutional Holders
294.0 institutions hold shares in Maravai LifeSciences Holdings Inc (MRVI), with institutional investors hold 107.03% of the company’s shares. The shares outstanding are 132.23M, and float is at 117.52M with Short Float at 6.73%. Institutions hold 105.57% of the Float.
The top institutional shareholder in the company is GTCR LLC with over 20.15 million shares valued at $144.27 million. The investor’s holdings represent 15.2267% of the MRVI Shares outstanding. As of 2024-06-30, the second largest holder is 12 WEST CAPITAL MANAGEMENT LP with 13.21 million shares valued at $94.59 million to account for 9.9833 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 10.75 million shares representing 8.1224% and valued at over $76.96 million, while BLACKROCK INC. holds 7.3519 of the shares totaling 9.73 million with a market value of $69.66 million.
Maravai LifeSciences Holdings Inc (MRVI) Insider Activity
The most recent transaction is an insider sale by GTCR INVESTMENT XI LLC, the company’s Director. SEC filings show that GTCR INVESTMENT XI LLC sold 9,940,974 shares of the company’s common stock on May 28 ’24 at a price of $9.81 per share for a total of $97.57 million. Following the sale, the insider now owns 20.15 million shares.
